NASDAQ
Aerovate Therapeutics, Inc. (AVTE) has a current ratio of 21.09x as of Tuesday, May 26, 2026. This represents a 25.50% decrease compared to its 12-month average of 28.31x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.